These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2945321)

  • 1. Various immunoglobulin preparations for intravenous use.
    Morell A
    Vox Sang; 1986; 51 Suppl 2():44-9. PubMed ID: 2945321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences among available immunoglobulin preparations for intravenous use.
    Skvaril F; Gardi A
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S43-8. PubMed ID: 2456510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A.
    Römer J; Späth PJ; Skvaril F; Nydegger UE
    Vox Sang; 1982 Feb; 42(2):74-80. PubMed ID: 6461133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin preparations: a comparative in vitro study of Fc mediated functions.
    Le Moli S; Nisini R; Fattorossi A; Matricardi PM; D'Amelio R
    J Clin Lab Immunol; 1989 Jun; 29(2):79-84. PubMed ID: 2632805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations].
    Barandun S; Skvaril F; Morell A
    Schweiz Med Wochenschr; 1976 Apr; 106(16):533-42. PubMed ID: 62393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological properties of immunoglobulin G and its split products [F(ab')2 and Fab].
    Sedlacek HH; Gronski P; Hofstaetter T; Kanzy EJ; Schorlemmer HU; Seiler FR
    Klin Wochenschr; 1983 Aug; 61(15):723-36. PubMed ID: 6194337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of F(ab')2 fragments from mouse IgG of various subclasses.
    Lamoyi E
    Methods Enzymol; 1986; 121():652-63. PubMed ID: 3088385
    [No Abstract]   [Full Text] [Related]  

  • 9. Conventional immunoglobulin therapy.
    Hitzig WH; Müntener U
    Birth Defects Orig Artic Ser; 1975; 11(1):339-42. PubMed ID: 50096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of diseases by means of immunoglobulins.
    Barandun S; Skvaril F; Morell A
    Monogr Allergy; 1975; 9():39-60. PubMed ID: 123313
    [No Abstract]   [Full Text] [Related]  

  • 11. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undegraded human immunoglobulin for intravenous use.
    Stephan W
    Vox Sang; 1975; 28(6):422-37. PubMed ID: 807036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the structural-functional properties of immunoglobulins G and their fragments using 1H-NMR].
    Khristoforov VS; Kutyshenko VP; Zav'ialov VP
    Bioorg Khim; 1987 Nov; 13(11):1446-64. PubMed ID: 3327502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination and organ distribution of intravenously administered allogeneic and xenogeneic IgG modifications. (Standard IgG, F (ab)2-fragments and beta-propiolactone treated IgG) in dogs.
    Ring J; Duswald KH; Bachmann T; von Scheel J; Stephan W; Brendel W
    Res Exp Med (Berl); 1978 Sep; 173(3):209-18. PubMed ID: 364571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation criteria for intravenous immunoglobulin G preparations].
    Nydegger UE
    Presse Med; 1983 Nov; 12(41):2619-24. PubMed ID: 6228800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunoglobulins for intravenous administration: preparation and properties.
    Kistler P; Steiger G
    Prog Immunobiol Stand; 1970; 4():92-4. PubMed ID: 4098282
    [No Abstract]   [Full Text] [Related]  

  • 17. Opsonic and physicochemical characteristics of intravenous immunoglobulin preparations.
    van Furth R; Braat AG; Leijh PC; Gardi A
    Vox Sang; 1987; 53(2):70-5. PubMed ID: 3500539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Theoretical and experimental studies on the conformation of the hinge regions in human immunoglobulin G subclasses].
    Denesiuk AI; Tishchenko VM; Abramov VM; Zav'ialov VP
    Mol Biol (Mosk); 1983; 17(6):1262-71. PubMed ID: 6656755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the immunoglobin G "hinge" region in heat aggregation and activation of complex-formation].
    Khristoforov VS; Persanov VM; Sukhomudrenko AG; Abramov VM; Zav'ialov VP
    Biofizika; 1987; 32(1):32-6. PubMed ID: 3493035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis and therapy with human immunoglobulins].
    Lahmann N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):587-95. PubMed ID: 2435624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.